Trevi Therapeutics Inc. (TRVI)
Trevi Therapeutics Max Pain By Strike
TRVI trades at $7.51, 50.2% above the near-term max pain of $5 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$8), reflecting growing call interest at higher strikes. High dispersion in max pain levels suggests competing forces and potential volatility.
Trevi Therapeutics Max Pain By Expiry
Max pain for TRVI shows an upward trend from 1 to 8, suggesting bullish positioning in longer-dated options. The 156% spread signals divergent expectations across timeframes. Most levels below 7.51 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 5 | -2.51 (-33.47%) |
| Oct 17, 2025 | 8 | 0.49 (6.45%) |
| Jan 16, 2026 | 4 | -3.51 (-46.77%) |
| Apr 17, 2026 | 1 | -6.51 (-86.69%) |